These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 4177468)
21. Selection of breast-cancer patients for adrenalectomy or hypophysectomy by determination of urinary 17-hydroxycorticosteroids and aetiocholanolone. BULBROOK RD; GREENWOOD FC; HAYWARD JL Lancet; 1960 May; 1(7135):1154-7. PubMed ID: 13805841 [No Abstract] [Full Text] [Related]
22. Indications for castration and adrenalectomy for advanced breast cancer. Fracchia AA Cancer; 1971 Dec; 28(6):1699-701. PubMed ID: 4331418 [No Abstract] [Full Text] [Related]
23. Breast cancer--the Bullbrook discriminant. Meyer KK Rocky Mt Med J; 1968 Oct; 65(10):53-9. PubMed ID: 5681761 [No Abstract] [Full Text] [Related]
24. [Surgery for hormonal purposes]. DARGENT M; MAYER M; COLON J J Med Lyon; 1962 Jan; 43():156-64. PubMed ID: 13883547 [No Abstract] [Full Text] [Related]
25. [Therapeutic possibilities in metastatic cancer of the breast with hypercalcaemia. (Apropos of 2 cases)]. Gorins A; Bloch-Michel H; Dussart N; Aristoff H Rev Rhum Mal Osteoartic; 1969 Nov; 36(11):575-81. PubMed ID: 4312628 [No Abstract] [Full Text] [Related]
26. [Variations in the urinary elimination of biological estrogens, total gonadotropins, 17-ketosteroids and 17-hydroxycorticoides under the action of norethisterone acetate administered in massive doses for metastatic breast cancers]. Netter A; Gorins A; Thevenet M Ann Endocrinol (Paris); 1969; 30(3):488-96. PubMed ID: 5358485 [No Abstract] [Full Text] [Related]
27. [Case of Cushing's syndrome with remarkable daily fluctuation of urinary 17-OHCS]. Inagaki H; Nakashio K; Koizumi S; Kogure H Nihon Rinsho; 1967 Nov; 25(11):2617-20. PubMed ID: 5628393 [No Abstract] [Full Text] [Related]
28. The value of urinary steroid estimations in the prediction of response to adrenalectomy or hypophysectomy. Hayward JL; Bulbrook RD Cancer Res; 1965 Aug; 25(7):1129-34. PubMed ID: 5843263 [No Abstract] [Full Text] [Related]
31. [ENDOCRINE SURGERY IN METASTASIZING BREAST CANCER]. SJOEGREN B Nord Med; 1963 Dec; 70():1357-62. PubMed ID: 14103688 [No Abstract] [Full Text] [Related]
32. [Indications of endocrino-surgical treatment of advanced cancer of the breast]. DOGLIOTTI AM; RUFFO A; MOLINATTI GM Minerva Ginecol; 1962 Jan; 14():63-6. PubMed ID: 13886947 [No Abstract] [Full Text] [Related]
33. SEVEN-YEAR SURVIVAL AFTER BILATERAL ADRENALECTOMY AND OOPHORECTOMY FOR CARCINOMATOSIS. TAYLOR H Proc R Soc Med; 1964 Aug; 57(8):676-8. PubMed ID: 14195856 [No Abstract] [Full Text] [Related]
34. Preliminary trial of aminoglutethimide in breast cancer. Griffiths CT; Hall TC; Saba Z; Barlow JJ; Nevinny HB Cancer; 1973 Jul; 32(1):31-7. PubMed ID: 4716782 [No Abstract] [Full Text] [Related]
35. Breast cancer--1. Management of advanced breast cancer. Rubens RD Nurs Times; 1975 Aug; 71(33):1287-9. PubMed ID: 49883 [No Abstract] [Full Text] [Related]
36. SELECTIVE CRITERIA FOR SURGICAL REMOVAL OF THE ENDOCRINE GLANDS IN ADVANCED BREAST CANCER. FAIRGRIEVE J Surg Gynecol Obstet; 1965 Feb; 120():371-85. PubMed ID: 14257953 [No Abstract] [Full Text] [Related]